BCM
ANRO icon

Bridgeway Capital Management’s Alto Neuroscience ANRO Stock Holding History

Bridgeway Capital Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Sell
50,653
-2,000
-4% -$46.2K 0.02% 672
2026
Q1 		$1.18M Sell
52,653
-25,000
-32% -$463K 0.02% 675
2025
Q4 		$1.38M Hold
77,653
– – 0.03% 637
2025
Q3 		$312K Buy
77,653
+23,553
+44% +$78.1K 0.01% 915
2025
Q2 		$119K Buy
54,100
+25,000
+86% +$59.5K ﹤0.01% 1045
2025
Q1 		$62.9K Buy
+29,100
New +$104K ﹤0.01% 1103

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Bridgeway Capital Management's ANRO Position: Q2 2026 in Review

Bridgeway Capital Management reduced its Alto Neuroscience (ANRO) stake by 3.8% in Q2 2026, selling an estimated $46.2K and leaving 50,653 shares worth $1.34M. The position accounts for 0.02% of the portfolio, ranked #672.

Bridgeway Capital Management first reported a position in ANRO in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.38M in Q4 2025. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Bridgeway Capital Management held 50,653 shares of Alto Neuroscience worth $1.34M as of Q2 2026.
  • Bridgeway Capital Management sold 2,000 Alto Neuroscience shares in Q2 2026, an estimated $46.2K.
  • Alto Neuroscience made up 0.02% of Bridgeway Capital Management's portfolio in Q2 2026, its #672 holding.
  • Bridgeway Capital Management first reported a position in Alto Neuroscience in Q1 2025 and has held it in 6 quarters since.
  • Bridgeway Capital Management's Alto Neuroscience position peaked at $1.38M in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.